How U.S. Payers View “Value” — And Why “Cost-Saving” and “Costs More” Don’t Always Mix

U.S. payers don’t define “value” the same way as clinicians or investors. This article breaks down how payers assess value — and how early-stage MedTech startups can build compelling strategies for reimbursement success.